Mehdi Abaszadeh

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Breast Cancer Cells

Induced Apoptosis

Molecular Dynamics

Endoplasmic Reticulum Stress

Top Venues

Iranian journal of pharmaceutical research : IJPR

This page only lists publications with an associated author ORCID identifier.

Publications

Touba Eslaminejad, Ehsan Faghih Mirzaei, Mehdi Abaszadeh
Synthesis, Antioxidant, Cytotoxicity, Induce Apoptosis Investigation and Docking Study of New Halogenated Dihydropyrano[3,2- b ]Chromene-3-Carbonitrile Derivatives on MCF-7 Breast Cancer Cell Line. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Touba Eslaminejad, Ehsan Faghih Mirzaei, Mehdi Abaszadeh
Synthesis, Antioxidant, Cytotoxicity, Induce Apoptosis Investigation and Docking Study of New Halogenated Dihydropyrano[3,2- b ]Chromene-3-Carbonitrile Derivatives on MCF-7 Breast Cancer Cell Line. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)